CCL Products Q1 FY27 Results Analysis: PAT Jumps 61%, Standalone PAT Falls 29%

CompoundingAI Research Updated July 27, 2026 2 min read
Positive

CCL Products (India) Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 1,200.45 Cr (+13.72% YoY) and PAT growth of +61.31% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 27, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,200.45 Cr (+13.72% YoY)
PAT (Q1)Rs. 116.87 Cr (+61.31% YoY)
EBITDA margin16.12% (+106 bps YoY)
EPS (Q1)Rs. 8.77 (+60.92% YoY)
Market capRs. 15,681.52 Cr
CMPRs. 1,174.40

Quarter Snapshot

CCL Products delivered 13.7% revenue growth and 61.3% PAT growth, with EBITDA margin expanding 106 bps. The Vietnam subsidiary is the profit engine, contributing 81% of group PAT. However, the effective tax rate collapsed to 9.4% (unsustainable) and standalone business PAT fell 28.6% due to high-cost inventory, tempering the quality of earnings.

Key Investment Insights

Key Positives

  • Consolidated revenue grew 13.72% YoY to Rs.1,200.45 Cr, led by subsidiary revenue (+19.76% YoY).
  • EBITDA grew 21.71% YoY to Rs.193.55 Cr, with margin expanding 106 bps to 16.12%.
  • PAT grew 61.31% YoY to Rs.116.87 Cr, driven by operating leverage and lower finance costs (-14.90% YoY).
  • Subsidiaries contributed 80.8% of group PAT (from 56.7% a year ago), with Vietnam PAT margin at ~15.9%.
  • Finance costs declined 14.90% YoY despite ongoing capex.

Risk Factors

  • Effective tax rate collapsed to 9.42% from 23.08% YoY, inflating PAT by ~Rs.18 Cr; normalisation to ~20% would reduce PAT growth to ~40%.
  • Standalone PAT declined 28.58% YoY as cost-of-materials ratio surged to 71.75% from 54.50% due to inventory lag.
  • Cost of materials ratio (consolidated) increased 649 bps YoY to 67.80%, though this is a temporary inventory-timing effect.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now